BENZODIAZEPINES QC LEVEL 1 BENZO QC1 U ADX

GUDID B800BENZOQC1UADX5

BENZODIAZEPINES QC LEVEL 1

UTAK LABORATORIES, INC.

Multiple-type clinical chemistry analyte profile IVD, control
Primary Device IDB800BENZOQC1UADX5
NIH Device Record Key533a150d-720a-4de8-b533-1f769de2779e
Commercial Distribution StatusIn Commercial Distribution
Brand NameBENZODIAZEPINES QC LEVEL 1
Version Model NumberBENZO QC1 U ADX
Catalog NumberBENZO QC1 U ADX
Company DUNS092519016
Company NameUTAK LABORATORIES, INC.
Device Count1
DM Exemptfalse
Pre-market Exempttrue
MRI Safety StatusLabeling does not contain MRI Safety Information
Human Cell/Tissue Productfalse
Device Kitfalse
Device Combination Productfalse
Single Usefalse
Lot Batchtrue
Serial Numberfalse
Manufacturing Datefalse
Expiration Datetrue
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latexfalse
RX Perscriptionfalse
OTC Over-The-Counterfalse

Customer Support Contacts

Phone1-888-882-5522
Emailwelovecontrol@utak.com
Phone1-888-882-5522
Emailwelovecontrol@utak.com
Phone1-888-882-5522
Emailwelovecontrol@utak.com
Phone1-888-882-5522
Emailwelovecontrol@utak.com
Phone1-888-882-5522
Emailwelovecontrol@utak.com
Phone1-888-882-5522
Emailwelovecontrol@utak.com
Phone1-888-882-5522
Emailwelovecontrol@utak.com
Phone1-888-882-5522
Emailwelovecontrol@utak.com
Phone1-888-882-5522
Emailwelovecontrol@utak.com
Phone1-888-882-5522
Emailwelovecontrol@utak.com
Phone1-888-882-5522
Emailwelovecontrol@utak.com
Phone1-888-882-5522
Emailwelovecontrol@utak.com
Phone1-888-882-5522
Emailwelovecontrol@utak.com

Device Dimensions

Total Volume10 Milliliter
Total Volume10 Milliliter
Total Volume10 Milliliter
Total Volume10 Milliliter
Total Volume10 Milliliter
Total Volume10 Milliliter
Total Volume10 Milliliter
Total Volume10 Milliliter
Total Volume10 Milliliter
Total Volume10 Milliliter
Total Volume10 Milliliter
Total Volume10 Milliliter
Total Volume10 Milliliter

Operating and Storage Conditions

Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius

Device Identifiers

Device Issuing AgencyDevice ID
HIBCCB800BENZOQC1UADX0 [Primary]
HIBCCB800BENZOQC1UADX5 [Package]
Contains: B800BENZOQC1UADX0
Package: BOX [10 Units]
In Commercial Distribution

FDA Product Code

LASDrug Specific Control Materials

Sterilization

Steralize Prior To Usefalse
Device Is Sterilefalse

Device Entry Metadata

Public Version StatusNew
Device Record StatusPublished
Public Version Number1
Public Version Date2025-01-17
Device Publish Date2025-01-09

Devices Manufactured by UTAK LABORATORIES, INC.

B800ALP1V2SSH5 - ALPRAZOLAM PLUS 1 2025-01-23 ALPRAZOLAM PLUS 1
B800ALP2V2SSH0 - ALPRAZOLAM PLUS 22025-01-23 ALPRAZOLAM PLUS 2
B800IMIP1000SFUW5 - IMIPRAMINE 1000 NG/ML2025-01-22 IMIPRAMINE 1000 NG/ML
B80091801UAL5 - BUPRENORPHINE HYDROLYSIS QC2025-01-21 BUPRENORPHINE HYDROLYSIS QC
B800MDLABS43V2HIGH0 - MD LABS 43 DRUGS HIGH2025-01-21 MD LABS 43 DRUGS HIGH
B800MDLABS43V2LOW5 - MD LABS 43 DRUGS LOW2025-01-21 MD LABS 43 DRUGS LOW
B800DOA1EXTBUFOFFMMC5 - DRUGS OF ABUSE LEVEL 1 2025-01-20 DRUGS OF ABUSE LEVEL 1
B800DOA2EXTBUFOFFMMC5 - DRUGS OF ABUSE LEVEL 2 2025-01-20 DRUGS OF ABUSE LEVEL 2

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.